Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    New press releases covering product updates, trial results, manufacturing investments, and corporate/financial news were added, while older items such as a pricing update and conference announcements were removed.
    Difference
    22%
    Check dated 2025-12-14T10:25:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    New press releases were added (including the 12/01/2025 Zepbound price reduction and 12/03/2025 FDA approval updates) and older items such as the 11/06/2025 obesity-access story were removed from the list.
    Difference
    42%
    Check dated 2025-12-07T07:49:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Adds new press-release items highlighting SABCS 2025 and ASH 2025 data, including EMBER-3 and PIKALO-1 results for Inluriyo, and BRUIN CLL-314/BRUIN CLL-313 data for Jaypirca.
    Difference
    24%
    Check dated 2025-11-30T03:15:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    New entries include Lilly Gateway Labs in Philadelphia and Citi Global Healthcare Conference participation. Removed items include LillyDirect/Walmart pricing news and the NVIDIA AI partnership.
    Difference
    39%
    Check dated 2025-11-23T00:56:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New items added include a press release about Tan France's campaign for Zepbound and a statement denying any affiliation with Mangoceuticals; older items such as the Team USA roster for Milano Cortina 2026 and Omvoh FDA approvals were removed.
    Difference
    8%
    Check dated 2025-11-15T22:20:28.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    New press releases announce two new Executive Committee members and leadership expansion, and expanded U.S. access to obesity medicines. Additional items include positive Phase 2 results for eloralintide and plans to build a $3 billion manufacturing facility in Katwijk, Netherlands to boost European production.
    Difference
    8%
    Check dated 2025-11-08T13:18:42.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.